JP5374685B2 - 新規hcvエントリー阻害剤 - Google Patents
新規hcvエントリー阻害剤 Download PDFInfo
- Publication number
- JP5374685B2 JP5374685B2 JP2008300937A JP2008300937A JP5374685B2 JP 5374685 B2 JP5374685 B2 JP 5374685B2 JP 2008300937 A JP2008300937 A JP 2008300937A JP 2008300937 A JP2008300937 A JP 2008300937A JP 5374685 B2 JP5374685 B2 JP 5374685B2
- Authority
- JP
- Japan
- Prior art keywords
- hcv
- entry inhibitor
- salts
- hcv entry
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- AKGIGSUIOWBKLL-UHFFFAOYSA-N CC(C)(C)c(cc(CCC(C)=O)cc1C(C)(C)C)c1O Chemical compound CC(C)(C)c(cc(CCC(C)=O)cc1C(C)(C)C)c1O AKGIGSUIOWBKLL-UHFFFAOYSA-N 0.000 description 1
- YLSKXOORRICBCF-UHFFFAOYSA-N CC(C)NCC(C)=O Chemical compound CC(C)NCC(C)=O YLSKXOORRICBCF-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明のHCVエントリー阻害剤の抗HCV作用確認試験
本発明のHCVエントリー阻害剤の細胞毒性試験
本発明のHCVエントリー阻害剤のSI値
従来のHCVエントリー阻害剤の抗HCV作用確認試験
従来のHCVエントリー阻害剤の細胞毒性試験
従来のHCVエントリー阻害剤のSI値
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008300937A JP5374685B2 (ja) | 2008-02-14 | 2008-11-26 | 新規hcvエントリー阻害剤 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008033598 | 2008-02-14 | ||
JP2008033598 | 2008-02-14 | ||
JP2008300937A JP5374685B2 (ja) | 2008-02-14 | 2008-11-26 | 新規hcvエントリー阻害剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009215280A JP2009215280A (ja) | 2009-09-24 |
JP5374685B2 true JP5374685B2 (ja) | 2013-12-25 |
Family
ID=41187520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008300937A Active JP5374685B2 (ja) | 2008-02-14 | 2008-11-26 | 新規hcvエントリー阻害剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5374685B2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012107589A1 (en) | 2011-02-11 | 2012-08-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of hcv infections |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2720549B2 (ja) * | 1989-11-08 | 1998-03-04 | 三菱化学株式会社 | 9―アミノアセチルアミノテトラヒドロアクリジン誘導体 |
US7612082B2 (en) * | 2004-10-28 | 2009-11-03 | Allergan, Inc. | Prostaglandin EP4 antagonists |
JP2008184403A (ja) * | 2007-01-29 | 2008-08-14 | Japan Health Science Foundation | 新規c型肝炎ウイルス阻害剤 |
-
2008
- 2008-11-26 JP JP2008300937A patent/JP5374685B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
JP2009215280A (ja) | 2009-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10987329B1 (en) | Combination therapy for coronavirus infections including the novel corona virus (COVID-19) | |
KR102174576B1 (ko) | 바이러스 질환 치료에서의 mek 억제제 | |
Pajak | Zieli nski, R | |
AU2011270165B2 (en) | Antitumor agent using compounds having kinase inhibitory effect in combination | |
RU2560676C2 (ru) | Противотуберкулезная композиция, содержащая соединения оксазола | |
US11931353B2 (en) | Methods of preventing or treating flavivirus virus infections and methods of inhibiting the entry of flvivirus, enterovirus or lentivirus into host cells | |
US11883376B2 (en) | Viral infection treatment with 5-aminolevulinic acid | |
JP7002444B2 (ja) | 医薬 | |
CN106963769A (zh) | 含pi3k抑制剂和perk抑制剂的药物组合物及其应用 | |
KR101957632B1 (ko) | 섬유화증 예방, 개선 또는 치료용 조성물 | |
JP2015145343A (ja) | ランソプラゾールの新規医薬用途 | |
WO2017155053A1 (ja) | 非アルコール性脂肪性肝疾患/非アルコール性脂肪性肝炎の治療剤 | |
JP5374685B2 (ja) | 新規hcvエントリー阻害剤 | |
CN115427045A (zh) | 用于治疗cov-229e或cov-oc43冠状病毒感染的4-(3-(吡啶-3-基)吡唑并[1,5-a]嘧啶-5-基)哌嗪 | |
US20040087597A1 (en) | Preventives and remedies for complications of diabetes | |
US20230026808A1 (en) | Compounds, compositions, and methods for treating ischemia-reperfusion injury and/or lung injury | |
JP2009286705A (ja) | 新規抗腫瘍物質アルキルクマリン類とその用途 | |
KR20230165754A (ko) | 암 및 전암성 유두종 바이러스 병변의 치료를 위한 2-s 리만타딘 및 2-r 리만타딘 | |
US20240091214A1 (en) | Lonafarnib for use in the treatment of viral infections | |
KR20100029528A (ko) | 아릴 디케토산(adk) 유도체를 유효성분으로 포함하는 사스 코로나 바이러스 저해용 조성물 | |
US11547737B2 (en) | Compositions and methods for treating virus infection | |
KR102535840B1 (ko) | 2,3,5-치환된 싸이오펜 화합물의 위장관기질종양 예방, 개선 또는 치료 용도 | |
AU2010212386A1 (en) | Topical antiviral therapeutic and prophylactic treatment of adenoviruses and their associated diseases | |
WO2012043838A1 (ja) | C型肝炎ウイルスの感染抑制剤 | |
KR20230143964A (ko) | 바이러스 감염증의 예방 또는 치료용 약학 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111107 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130813 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5374685 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |